Podcasts

Sara Holoubek, CEO of Luminary Labs, joins the podcast fresh off a panel she led at last week’s Hall of Femme event on changes that can prevent employee burnout.

IQVIA’s Michael Kleinrock joins us from the floor of the BIO convention to discuss a panel he moderated on solutions to curbing the opioid epidemic on this week’s episode.

inThought Research’s Michelle Rivera speaks with MM&M’s executive editor Marc Iskowitz about the pathophysiology of spinal muscular atrophy, the SMA drug pipeline and how payers may react to what is the most expensive single-dose drug ever.

Sharon Callahan, CEO of TBWA\WorldHealth and chief client officer of the Omnicom Health Group, joined MM&M senior editor Larry Dobrow to discuss HHS’ new rule on the disclosure of pricing information in TV ads and the state of the network-agency union.

In this episode, Megan Coder talks about the leading firms in digital therapeutics, what the relationship is between DTx firms and pharma/payers and how they’re using real world evidence studies to prove their value.

In this wide-ranging interview, Ogilvy Health’s Andrew Schirmer spoke candidly about the state of DTC advertising, about the WPP shop’s integration with Ogilvy, his top picks for standout creative, involvement of agencies in public health, and more.

We’re calling today’s episode of The MM&M Podcast “Not Your Father’s Dudnyk” during which Marc Iskowitz and Larry Dobrow interview Tom Dudnyk about why he started his own agency and discuss the Transforming Healthcare conference panel about the future of value-based reimbursement.

Karen Newmark, executive director of the Point of Care Communications Council (PoC3), talks about how she’s working to restore advertiser confidence in the POC channel and new verification and validation standards coming out in May.

Nancy Beesley, president and founding partner of HCB Health, discusses building out Austin’s budding med-comms industry and how she has adjusted to life in the Southwest.